Skip to main content
Top
Published in: BMC Public Health 1/2024

Open Access 01-12-2024 | Tuberculosis | Research

Evaluation of a population-wide, systematic screening initiative for tuberculosis on Daru island, Western Province, Papua New Guinea

Authors: Paison Dakulala, Margaret Kal, Alice Honjepari, Lucy Morris, Richard Rehan, Simon Peter Akena, Andrew J. Codlin, Narantuya Jadambaa, Tauhid Islam, Manami Yanagawa, Fukushi Morishita

Published in: BMC Public Health | Issue 1/2024

Login to get access

Abstract

Background

A population-wide, systematic screening initiative for tuberculosis (TB) was implemented on Daru island in the Western Province of Papua New Guinea, where TB is known to be highly prevalent. The initiative used a mobile van equipped with a digital X-ray device, computer-aided detection (CAD) software to identify TB-related abnormalities on chest radiographs, and GeneXpert machines for follow-on diagnostic testing. We describe the results of the TB screening initiative, evaluate its population-level impact and examine risk factors associated with TB detection.

Methods

Through a retrospective review of screening data, we assessed the effectiveness of the screening by examining the enrolment coverage and the proportion of people with TB among screened subjects. A cascade analysis was performed to illustrate the flow of participants in the screening algorithm. We conducted univariate and multivariate analyses to identify factors associated with TB. Furthermore, we estimated the number of additional cases detected by the project by examining the trend of routine TB case notifications during the intervention period, compared to the historical baseline cases and trend-adjusted expected cases.

Results

Of the island’s 18,854 residents, 8,085 (42.9%) were enrolled and 7,970 (98.6%) had chest X-ray interpreted by the CAD4TB software. A total of 1,116 (14.0%) participants were considered to have abnormal CXR. A total of 69 Xpert-positive cases were diagnosed, resulting in a detection rate of 853 per 100 000 population screened. 19.4% of people with TB had resistance to rifampicin. People who were in older age groups (aOR 6.6, 95%CI: 1.5–29.1 for the 45–59 age group), were severely underweight (aOR 2.5, 95%CI:1.0-6.1) or underweight (aOR 2.1, 95%CI: 1.1–3.8), lived in households < 5 people (aOR 3.4, 95%CI:1.8–6.6) and had a past history of TB (aOR 2.1, 95%CI: 1.2–3.6) were more likely to have TB. The number of bacteriologically confirmed TB notified during the intervention period was 79.3% and 90.8% higher than baseline notifications and forecasted notifications, respectively.

Conclusion

The screening project demonstrated its effectiveness with the high Xpert-positive TB prevalence among the participants and by successfully yielding additional cases of bacteriologically confirmed TB including rifampicin-resistant TB. The results and lessons learnt from the project should inform future TB screening initiatives in Papua New Guinea.
Appendix
Available only for authorised users
Literature
1.
go back to reference World Health Organization. Global tuberculosis Report 2021. Geneva; 2021. World Health Organization. Global tuberculosis Report 2021. Geneva; 2021.
2.
go back to reference United Nations. Political declearation of the UN general assembly high-level meeting. New York; 2018. United Nations. Political declearation of the UN general assembly high-level meeting. New York; 2018.
3.
go back to reference Kendall EA, Shrestha S, Dowdy DW. The epidemiological importance of subclinical tuberculosis a critical reappraisal. Am J Respir Crit Care Med. 2021;203:168–74.CrossRefPubMedPubMedCentral Kendall EA, Shrestha S, Dowdy DW. The epidemiological importance of subclinical tuberculosis a critical reappraisal. Am J Respir Crit Care Med. 2021;203:168–74.CrossRefPubMedPubMedCentral
5.
go back to reference World Health Organization. WHO consolidated guidelines on tuberculosis. Module 2: Screening. Geneva; 2021. World Health Organization. WHO consolidated guidelines on tuberculosis. Module 2: Screening. Geneva; 2021.
6.
go back to reference Aia P, Wangchuk L, Morishita F, Kisomb J, Yasi R, Kal M et al. Epidemiology of tuberculosis in Papua New Guinea: analysis of case notification and treatment-outcome data, 2008–2016. West Pacific Surveill Response J [Internet]. 2018;9(2):1–11. Available from: www.wpro.who.int/wpsar. Aia P, Wangchuk L, Morishita F, Kisomb J, Yasi R, Kal M et al. Epidemiology of tuberculosis in Papua New Guinea: analysis of case notification and treatment-outcome data, 2008–2016. West Pacific Surveill Response J [Internet]. 2018;9(2):1–11. Available from: www.​wpro.​who.​int/​wpsar.
7.
go back to reference Aia P, Kal M, Lavu E, John LN, Johnson K, Coulter C et al. The burden of drug-resistant tuberculosis in Papua New Guinea: results of a large population-based survey. PLoS ONE. 2016;11(3). Aia P, Kal M, Lavu E, John LN, Johnson K, Coulter C et al. The burden of drug-resistant tuberculosis in Papua New Guinea: results of a large population-based survey. PLoS ONE. 2016;11(3).
8.
go back to reference Morris L, Hiasihri S, Chan G, Honjepari A, Tugo O, Taune M, et al. The emergency response to multidrug-resistant tuberculosis in Daru, Western Province, Papua New Guinea, 2014–2017. Public Heal Action. 2019;9(1):4–11.CrossRef Morris L, Hiasihri S, Chan G, Honjepari A, Tugo O, Taune M, et al. The emergency response to multidrug-resistant tuberculosis in Daru, Western Province, Papua New Guinea, 2014–2017. Public Heal Action. 2019;9(1):4–11.CrossRef
9.
go back to reference Blok L, Creswell J, Stevens R, Brouwer M, Ramis O, Weil O et al. A pragmatic approach to measuring, monitoring and evaluating interventions for improved tuberculosis case detection. Int Health [Internet]. 2014 Sep [cited 2015 Feb 20];6(3):181–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25100402. Blok L, Creswell J, Stevens R, Brouwer M, Ramis O, Weil O et al. A pragmatic approach to measuring, monitoring and evaluating interventions for improved tuberculosis case detection. Int Health [Internet]. 2014 Sep [cited 2015 Feb 20];6(3):181–8. Available from: http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​25100402.
11.
go back to reference Shapiro AE, Chakravorty R, Akande T, Lonnroth K, Jonathan E. Golub. A systematic review of the number needed to screen to detect a case of active tuberculosis in different risk groups. Geneva; 2013. Shapiro AE, Chakravorty R, Akande T, Lonnroth K, Jonathan E. Golub. A systematic review of the number needed to screen to detect a case of active tuberculosis in different risk groups. Geneva; 2013.
12.
go back to reference Codlin AJ, Monyrath C, Ky M, Gerstel L, Creswell J, Eang MT. Results from a roving, active case finding initiative to improve tuberculosis detection among older people in rural cambodia using the Xpert MTB/RIF assay and chest X-ray. J Clin Tuberc Other Mycobact Dis [Internet]. 2018;13(October):22–7. https://doi.org/10.1016/j.jctube.2018.11.001. Codlin AJ, Monyrath C, Ky M, Gerstel L, Creswell J, Eang MT. Results from a roving, active case finding initiative to improve tuberculosis detection among older people in rural cambodia using the Xpert MTB/RIF assay and chest X-ray. J Clin Tuberc Other Mycobact Dis [Internet]. 2018;13(October):22–7. https://​doi.​org/​10.​1016/​j.​jctube.​2018.​11.​001.
14.
go back to reference Chu P, Chang Y, Zhang X, Han S, Jin Y, Yu Y, et al. Epidemiology of extrapulmonary tuberculosis among pediatric inpatients in mainland China: a descriptive, multicenter study. Emerg Microbes Infect. 2022;11(1):1090–102.CrossRefPubMedPubMedCentral Chu P, Chang Y, Zhang X, Han S, Jin Y, Yu Y, et al. Epidemiology of extrapulmonary tuberculosis among pediatric inpatients in mainland China: a descriptive, multicenter study. Emerg Microbes Infect. 2022;11(1):1090–102.CrossRefPubMedPubMedCentral
15.
go back to reference Lavu EK, Johnson K, Banamu J, Pandey S, Carter R, Coulter C, et al. Drug-resistant tuberculosis diagnosis since Xpert ® MTB/RIF introduction in Papua New Guinea, 2012–2017. Public Heal Action. 2019;9(1):12–8.CrossRef Lavu EK, Johnson K, Banamu J, Pandey S, Carter R, Coulter C, et al. Drug-resistant tuberculosis diagnosis since Xpert ® MTB/RIF introduction in Papua New Guinea, 2012–2017. Public Heal Action. 2019;9(1):12–8.CrossRef
16.
go back to reference Cheng J, Sun YN, Zhang CY, Yu YL, Tang LH, Peng H, et al. Incidence and risk factors of tuberculosis among the elderly population in China: a prospective cohort study. Infect Dis Poverty. 2020;9(1):1–13.CrossRef Cheng J, Sun YN, Zhang CY, Yu YL, Tang LH, Peng H, et al. Incidence and risk factors of tuberculosis among the elderly population in China: a prospective cohort study. Infect Dis Poverty. 2020;9(1):1–13.CrossRef
17.
go back to reference Lansang MAD, Alejandria MM, Law I, Juban NR, Amarillo MLE, Sison OT, et al. High TB burden and low notification rates in the Philippines: the 2016 national TB prevalence survey. PLoS ONE. 2021;16(6 June):1–16. Lansang MAD, Alejandria MM, Law I, Juban NR, Amarillo MLE, Sison OT, et al. High TB burden and low notification rates in the Philippines: the 2016 national TB prevalence survey. PLoS ONE. 2021;16(6 June):1–16.
18.
go back to reference Leung CC, Lam TH, Chan WM, Yew WW, Ho KS, Leung G, et al. Lower risk of tuberculosis in obesity. Arch Intern Med. 2007;167(12):1297–304.CrossRefPubMed Leung CC, Lam TH, Chan WM, Yew WW, Ho KS, Leung G, et al. Lower risk of tuberculosis in obesity. Arch Intern Med. 2007;167(12):1297–304.CrossRefPubMed
20.
go back to reference Semba RD, Darnton-Hill I, de Pee S. Addressing tuberculosis in the context of malnutrition and HIV coinfection. Food Nutr Bull. 2010;31(4):345–64.CrossRef Semba RD, Darnton-Hill I, de Pee S. Addressing tuberculosis in the context of malnutrition and HIV coinfection. Food Nutr Bull. 2010;31(4):345–64.CrossRef
21.
go back to reference Padmapriyadarsini C, Shobana M, Lakshmi M, Beena T, Swaminathan S. Undernutrition & Tuberculosis in India: Situation analysis & the way forward. Indian J Med Res. 2016;144(1):11–20.CrossRefPubMedPubMedCentral Padmapriyadarsini C, Shobana M, Lakshmi M, Beena T, Swaminathan S. Undernutrition & Tuberculosis in India: Situation analysis & the way forward. Indian J Med Res. 2016;144(1):11–20.CrossRefPubMedPubMedCentral
22.
go back to reference Narasimhan P, Wood J, MacIntyre CR. Mathai, D. Review article risk factors for tuberculosis. Pulm Med. 2013;2013:1–11.CrossRef Narasimhan P, Wood J, MacIntyre CR. Mathai, D. Review article risk factors for tuberculosis. Pulm Med. 2013;2013:1–11.CrossRef
23.
go back to reference Jops P, Kupul M, Trumb RN, Cowan J, Graham SM, Bell S, et al. Exploring tuberculosis riskscapes in a Papua New Guinean hotspot. Qual Health Res. 2022;32(11):1747–62.CrossRefPubMed Jops P, Kupul M, Trumb RN, Cowan J, Graham SM, Bell S, et al. Exploring tuberculosis riskscapes in a Papua New Guinean hotspot. Qual Health Res. 2022;32(11):1747–62.CrossRefPubMed
24.
go back to reference Pham BN, Abori N, Silas VD, Jorry R, Rao C, Okely T et al. Tuberculosis and HIV / AIDS- attributed mortalities and associated sociodemographic factors in Papua New Guinea: evidence from the comprehensive health and epidemiological surveillance system. 2022;1–11. Pham BN, Abori N, Silas VD, Jorry R, Rao C, Okely T et al. Tuberculosis and HIV / AIDS- ­ attributed mortalities and associated sociodemographic factors in Papua New Guinea: evidence from the comprehensive health and epidemiological surveillance system. 2022;1–11.
25.
go back to reference Coleman M, Hill J, Timeon E, Tonganibeia A, Eromanga B, Islam T, et al. Population-wide active case finding and prevention for tuberculosis and leprosy elimination in Kiribati: the PEARL study protocol. BMJ Open. 2022;12(4):e055295.CrossRefPubMedPubMedCentral Coleman M, Hill J, Timeon E, Tonganibeia A, Eromanga B, Islam T, et al. Population-wide active case finding and prevention for tuberculosis and leprosy elimination in Kiribati: the PEARL study protocol. BMJ Open. 2022;12(4):e055295.CrossRefPubMedPubMedCentral
26.
go back to reference Ragonnet R, Williams BM, Largen A, Nasa J, Jack T, Langinlur MK, et al. Estimating the long-term effects of mass screening for latent and active tuberculosis in the Marshall Islands. Int J Epidemiol. 2022;51(5):1433–45.CrossRefPubMedPubMedCentral Ragonnet R, Williams BM, Largen A, Nasa J, Jack T, Langinlur MK, et al. Estimating the long-term effects of mass screening for latent and active tuberculosis in the Marshall Islands. Int J Epidemiol. 2022;51(5):1433–45.CrossRefPubMedPubMedCentral
Metadata
Title
Evaluation of a population-wide, systematic screening initiative for tuberculosis on Daru island, Western Province, Papua New Guinea
Authors
Paison Dakulala
Margaret Kal
Alice Honjepari
Lucy Morris
Richard Rehan
Simon Peter Akena
Andrew J. Codlin
Narantuya Jadambaa
Tauhid Islam
Manami Yanagawa
Fukushi Morishita
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2024
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-024-17918-y

Other articles of this Issue 1/2024

BMC Public Health 1/2024 Go to the issue